{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:31:33Z","timestamp":1773369093646,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"unspecified","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2026,2,25]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately a third of the global population. Early identification is critical for timely intervention, yet effective screening tools remain limited. The American Heart Association\u2019s Life\u2019s Simple 7 (LS7), originally developed to assess cardiovascular health, captures several metabolic domains that overlap with the diagnostic criteria of MASLD. Consequently, observed associations between LS7 and MASLD are expected to partly reflect shared metabolic components rather than independent risk prediction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed data from 3204 participants undergoing screening colonoscopy in the Salzburg Colon Cancer Prevention Initiative (Sakkopi). LS7 was derived from seven modifiable lifestyle factors (smoking, body mass index, blood pressure, cholesterol, fasting glucose, physical activity and diet). MASLD was assessed using abdominal ultrasonography, while liver fibrosis was evaluated through non-invasive markers (Aspartate Aminotransferase to Platelet Ratio Index and transient elastography). Poisson regression with robust SEs was used to estimate risk ratios (RRs) for MASLD and liver fibrosis across LS7 categories (poor: 0\u20134, intermediate: 5\u20139, ideal: 10\u201314), adjusting for age, sex and socioeconomic status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MASLD prevalence was highest in individuals with poor LS7 (82%) compared with those with intermediate (47%) and ideal (16%) scores. Higher LS7 was significantly associated with a lower risk of MASLD (RR 0.80; 95% CI 0.79 to 0.82; p&lt;0.001) and liver fibrosis after adjustment for confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LS7 showed a strong association with MASLD and hepatic steatosis, while associations with non-invasive fibrosis markers were weaker and marker-dependent, underscoring the close interplay between cardiometabolic health and liver disease. Future studies should evaluate whether changes in LS7 over time are associated with longitudinal changes in hepatic steatosis and fibrosis-related outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2026-003982","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:00:18Z","timestamp":1773327618000},"page":"e003982","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Life\u2019s Simple 7 with metabolic-associated steatotic liver disease and non-invasive fibrosis markers"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8839-0523","authenticated-orcid":false,"given":"Hannah","family":"Hofer","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Saint John of God Hospital, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wernly","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, General Hospital Oberndorf, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Semmler","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Flamm","sequence":"additional","affiliation":[{"name":"Institute of General Practice, Paracelsus Medical University, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"V\u00f6lkerer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, General Hospital Oberndorf, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1149-7633","authenticated-orcid":false,"given":"Franz","family":"Singhartinger","sequence":"additional","affiliation":[{"name":"Department of Surgery, Salzburger Landeskliniken Universit\u00e4tsklinikum Salzburg, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Erkens","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Ausserwinkler","sequence":"additional","affiliation":[{"name":"Clinic I for Internal Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar","family":"Aigner","sequence":"additional","affiliation":[{"name":"Clinic I for Internal Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Datz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, General Hospital Oberndorf, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Wernly","sequence":"additional","affiliation":[{"name":"Clinic I for Internal Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"2026031208001062000_13.1.e003982.1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000604"},{"key":"2026031208001062000_13.1.e003982.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.036"},{"key":"2026031208001062000_13.1.e003982.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2412865"},{"key":"2026031208001062000_13.1.e003982.4","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"},{"key":"2026031208001062000_13.1.e003982.5","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520"},{"key":"2026031208001062000_13.1.e003982.6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"2026031208001062000_13.1.e003982.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"2026031208001062000_13.1.e003982.8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008424","article-title":"American Heart Association\u2019s Life Simple 7 and Risk of Atrial Fibrillation in a Population Without Known Cardiovascular Disease: The ARIC (Atherosclerosis Risk in Communities) Study","volume":"7","author":"Garg","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026031208001062000_13.1.e003982.9","doi-asserted-by":"crossref","DOI":"10.3390\/nu14245344","article-title":"Ideal Cardiovascular Health Metrics Are Associated with Reduced Severity of Hepatic Steatosis and Liver Fibrosis Detected by Transient Elastography","volume":"14","author":"Fan","year":"2022","journal-title":"Nutrients"},{"key":"2026031208001062000_13.1.e003982.10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313884"},{"key":"2026031208001062000_13.1.e003982.11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326874"},{"key":"2026031208001062000_13.1.e003982.12","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med"},{"key":"2026031208001062000_13.1.e003982.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.005"},{"key":"2026031208001062000_13.1.e003982.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.03.027"},{"key":"2026031208001062000_13.1.e003982.15","unstructured":"American heart association\u2019s life\u2019s simple 7: lifestyle recommendations, polygenic risk, and lifetime risk of coronary heart disease | circulation."},{"key":"2026031208001062000_13.1.e003982.16","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001078"},{"key":"2026031208001062000_13.1.e003982.17","doi-asserted-by":"crossref","first-page":"e2394","DOI":"10.1210\/clinem\/dgac102","article-title":"Relationship of American Heart Association\u2019s Life Simple 7, Ectopic Fat, and Insulin Resistance in 5 Racial\/Ethnic Groups","volume":"107","author":"Chevli","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031208001062000_13.1.e003982.18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.amepre.2018.09.021","article-title":"Life\u2019s Simple 7 and Peripheral Artery Disease: The Multi-Ethnic Study of Atherosclerosis","volume":"56","author":"Unkart","year":"2019","journal-title":"Am J Prev Med"},{"key":"2026031208001062000_13.1.e003982.19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00592-024-02277-2","article-title":"Associations between life\u2019s essential 8 and metabolic health among us adults: insights of NHANES from 2005 to 2018","volume":"61","author":"Yang","year":"2024","journal-title":"Acta Diabetol"},{"key":"2026031208001062000_13.1.e003982.20","doi-asserted-by":"crossref","first-page":"17188","DOI":"10.1038\/s41598-024-67728-w","article-title":"Association of Life\u2019s Essential 8 with metabolic dysfunction-associated steatotic liver disease (MASLD), a cross-sectional study from the NHANES 2003\u20132018","volume":"14","author":"Liu","year":"2024","journal-title":"Sci Rep"},{"key":"2026031208001062000_13.1.e003982.21","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i2.97741","article-title":"Association of Life\u2019s Essential 8 and Life\u2019s Simple 7 with metabolic-associated fatty liver disease in the United States","volume":"17","author":"Fu","year":"2025","journal-title":"World J Hepatol"},{"key":"2026031208001062000_13.1.e003982.22","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1403720","article-title":"Associations of life\u2019s essential 8 with MAFLD and liver fibrosis among US adults: a nationwide cross-section study","volume":"11","author":"Liang","year":"2024","journal-title":"Front Nutr"},{"key":"2026031208001062000_13.1.e003982.23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050610","article-title":"Cardiovascular Health Metrics in the Development and Regression of Nonalcoholic Fatty Liver Disease: A Cohort Study","volume":"8","author":"Jang","year":"2019","journal-title":"J Clin Med"},{"key":"2026031208001062000_13.1.e003982.24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.atherosclerosis.2018.11.012","article-title":"Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey","volume":"284","author":"Mazidi","year":"2019","journal-title":"Atherosclerosis"},{"key":"2026031208001062000_13.1.e003982.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101133"},{"key":"2026031208001062000_13.1.e003982.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"2026031208001062000_13.1.e003982.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30652-X"},{"key":"2026031208001062000_13.1.e003982.28","doi-asserted-by":"crossref","unstructured":"Newsome PN , Buchholtz K , Cusi K , et al . A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. ESPE 2021. doi:10.1530\/ey.18.15.7","DOI":"10.1530\/ey.18.15.7"},{"key":"2026031208001062000_13.1.e003982.29","article-title":"Tirzepatide for the treatment of metabolic dysfunction-associated steatohepatitis with liver fibrosis: results of the synergy-nash phase 2 trial","volume":"20","author":"Loomba","year":"2025","journal-title":"Diabetol Stoffwechs"},{"key":"2026031208001062000_13.1.e003982.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00803-X"},{"key":"2026031208001062000_13.1.e003982.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2026-003982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:00:24Z","timestamp":1773327624000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2026-003982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,12]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/openhrt-2026-003982"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2026-003982","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}